TY - JOUR AU - Palmeiro, B. S. PY - 2013 DA - 2013// TI - Ciclosporin in veterinary dermatology JO - Vet Clin North Am Small Anim Pract VL - 43 UR - https://doi.org/10.1016/j.cvsm.2012.09.007 DO - 10.1016/j.cvsm.2012.09.007 ID - Palmeiro2013 ER - TY - JOUR AU - Forsythe, P. AU - Paterson, S. PY - 2014 DA - 2014// TI - Ciclosporin 10 years on: indications and efficacy JO - Vet Rec VL - 174 UR - https://doi.org/10.1136/vr.102484 DO - 10.1136/vr.102484 ID - Forsythe2014 ER - TY - JOUR AU - Steffan, J. AU - Favrot, C. AU - Mueller, R. PY - 2006 DA - 2006// TI - A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs JO - Vet Dermatol VL - 17 UR - https://doi.org/10.1111/j.1365-3164.2005.00491.x DO - 10.1111/j.1365-3164.2005.00491.x ID - Steffan2006 ER - TY - JOUR AU - Kovalik, M. AU - Taszkun, I. AU - Pomorski, Z. AU - Kozak, M. AU - Pomorska, D. AU - Szczepanik, M. PY - 2011 DA - 2011// TI - Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells JO - Vet Rec VL - 168 UR - https://doi.org/10.1136/vr.c7365 DO - 10.1136/vr.c7365 ID - Kovalik2011 ER - TY - JOUR AU - Steffan, J. AU - Parks, C. AU - Seewald, W. PY - 2005 DA - 2005// TI - Clinical trial evaluating the efficacy and safety of ciclosporin in dogs with atopic dermatitis JO - J Am Vet Med Assoc VL - 226 UR - https://doi.org/10.2460/javma.2005.226.1855 DO - 10.2460/javma.2005.226.1855 ID - Steffan2005 ER - TY - JOUR AU - Olivry, T. AU - DeBoer, D. J. AU - Favrot, C. AU - Jackson, H. AU - Mueller, R. S. AU - Nuttall, T. PY - 2010 DA - 2010// TI - Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis JO - Vet Dermatol VL - 21 UR - https://doi.org/10.1111/j.1365-3164.2010.00889.x DO - 10.1111/j.1365-3164.2010.00889.x ID - Olivry2010 ER - TY - JOUR AU - Olivry, T. AU - Bizikova, P. PY - 2013 DA - 2013// TI - A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs JO - Vet Dermatol VL - 24 UR - https://doi.org/10.1111/j.1365-3164.2012.01088.x DO - 10.1111/j.1365-3164.2012.01088.x ID - Olivry2013 ER - TY - JOUR AU - Kovalik, M. AU - Thoday, K. L. AU - Broek, A. H. M. PY - 2012 DA - 2012// TI - The use of Cyclosporine A in veterinary dermatology JO - Vet J VL - 193 UR - https://doi.org/10.1016/j.tvjl.2012.03.027 DO - 10.1016/j.tvjl.2012.03.027 ID - Kovalik2012 ER - TY - JOUR AU - Guaguère, E. AU - Steffan, J. AU - Olivry, T. PY - 2004 DA - 2004// TI - Cyclosporin A: a new drug in the field of canine dermatology JO - Vet Dermatol VL - 15 UR - https://doi.org/10.1111/j.1365-3164.2004.00376.x DO - 10.1111/j.1365-3164.2004.00376.x ID - Guaguère2004 ER - TY - JOUR AU - Steffan, J. AU - Maurer, M. AU - Ro Hlfs, A. PY - 2003 DA - 2003// TI - Cyclosporin concentration in the skin following oral administration JO - Vet Dermatol VL - 14 UR - https://doi.org/10.1046/j.1365-3164.2003.00318.x DO - 10.1046/j.1365-3164.2003.00318.x ID - Steffan2003 ER - TY - JOUR AU - Navarro, C. AU - Crastes, N. AU - Benizeau, E. AU - McGahie, D. PY - 2015 DA - 2015// TI - Voluntary acceptance and consumption of two oral ciclosporin formulations in dogs: two randomised, controlled studies JO - Irish Veterinary Journal VL - 68 UR - https://doi.org/10.1186/s13620-015-0031-8 DO - 10.1186/s13620-015-0031-8 ID - Navarro2015 ER - TY - JOUR AU - Hauschke, D. AU - Steinijans, V. W. AU - Diletti, E. AU - Burke, M. PY - 1992 DA - 1992// TI - Sample size determination for bioequivalence assessment using a multiplicative model JO - J Pharmacokinet Biopharm VL - 20 UR - https://doi.org/10.1007/BF01061471 DO - 10.1007/BF01061471 ID - Hauschke1992 ER - TY - JOUR AU - Steffan, J. AU - Strehlau, G. AU - Maurer, M. AU - Rohlfs, A. PY - 2004 DA - 2004// TI - Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs JO - J Vet Pharmacol Ther VL - 27 UR - https://doi.org/10.1111/j.1365-2885.2004.00587.x DO - 10.1111/j.1365-2885.2004.00587.x ID - Steffan2004 ER - TY - STD TI - Guidelines for the conduct of bioequivalence studies for veterinary medicinal products. EMEA/CVMP/016/00-Rev2. [http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/04/WC500105372.pdf]. Accessed 31 Oct 2014. UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/04/WC500105372.pdf ID - ref14 ER - TY - JOUR AU - McBride, J. H. AU - Rodgerson, D. O. AU - Park, S. S. AU - Reyes, A. F. PY - 1989 DA - 1989// TI - Measurement of Cyclosporine in Plasma from Patients with Various Transplants: HPLC and Radioimmunoasay with a Specifc Monoclonal Antibody Compared JO - Clin Chem VL - 35 ID - McBride1989 ER - TY - STD TI - Ghosh C, Chakraborty B (2012) LC-MS Methods for Regulated Bioequivalence Studies: Do we Need to Worry about Matrix Effects? [http://dx.doi.org/10.4172/scientificreports.424]. Accessed 31 Oct 2014. ID - ref16 ER - TY - JOUR AU - Core, P. PY - 2010 DA - 2010// TI - Narrow therapeutic index drugs: bioequivalence and generics JO - Presse Med VL - 39 UR - https://doi.org/10.1016/j.lpm.2009.09.017 DO - 10.1016/j.lpm.2009.09.017 ID - Core2010 ER - TY - BOOK AU - Niazi, S. K. PY - 2014 DA - 2014// TI - Handbook of Bioequivalence Testing PB - CRC Press CY - New York ID - Niazi2014 ER - TY - JOUR PY - 1992 DA - 1992// TI - Bioavailability and bioequivalence requirements JO - Fed Reg VL - 57 ID - ref19 ER - TY - STD TI - Food and Drug Administration (FDA) Code of Federal Register: 21 CFR 320, 24 [http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=320.24]. Accessed 31 Oct 2014. UR - http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=320.24 ID - ref20 ER - TY - STD TI - Food and Drug Administration (FDA) Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations [http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidance/ucm389370.pdf]. Accessed 31 Oct 2014. UR - http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidance/ucm389370.pdf ID - ref21 ER -